Patent US5434166A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5434166A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods of inhibiting demyelinating and desmyelinating diseases

Assignee: Eli Lilly and Co
•
Filing: 1994-08-22
•
Granted: 1995-07-18
•
Expires: 2014-08-22
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method of inhibiting demyelinating or dysmyelinating diseases or their symptoms comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR1## wherein R 1 and R 3 are independently hydrogen, --CH 3 , ##STR2## wherein Ar is optionally substituted phenyl; R 2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.

Inventors

  • 👤 Andrew L. Glasebrook

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:22
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/38; A61P; A61P25/00

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 64 words
A method of treating multiple sclerosis comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR5## wherein R 1 and R 3 are independently hydrogen, --CH 3 ; ##STR6## wherein Ar is optionally substituted phenyl; R 2 is selected from the group consisting of pyrrolidine, hexamethylenemino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
Claim 2
Independent Claim 64 words
A method of treating multiple sclerosis comprising administering to a human in need thereof an effective amount of a compound having the formula ##STR5## wherein R 1 and R 3 are independently hydrogen, --CH 3 ; ##STR6## wherein Ar is optionally substituted phenyl; R 2 is selected from the group consisting of pyrrolidine, hexamethylenemino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.

References Cited (Backward Citations)

US4133814A Cited
US4380635A Cited
US4418068A Cited
US5075321A Cited
WO1993010113A1 Cited
WO1993010741A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-07-17 1999-01-16 1999-07-18 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-07-17 2003-01-16 2003-07-18 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-07-17 2007-01-16 2007-07-18 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag